Menu
GeneBe

RECQL5

RecQ like helicase 5, the group of RecQ like helicases

Basic information

Region (hg38): 17:75626844-75667189

Links

ENSG00000108469NCBI:9400OMIM:603781HGNC:9950Uniprot:O94762AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • coronary artery disorder (Limited), mode of inheritance: AR
  • breast cancer (Limited), mode of inheritance: AD

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the RECQL5 gene.

  • Inborn genetic diseases (62 variants)
  • not provided (17 variants)
  • RECQL5-related condition (16 variants)
  • not specified (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the RECQL5 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
4
clinvar
1
clinvar
5
missense
60
clinvar
7
clinvar
7
clinvar
74
nonsense
1
clinvar
1
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
1
clinvar
1
splice region
2
2
non coding
9
clinvar
1
clinvar
10
Total 0 0 70 13 8

Variants in RECQL5

This is a list of pathogenic ClinVar variants found in the RECQL5 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
17-75627448-G-A RECQL5-related disorder Uncertain significance (Feb 12, 2024)3054599
17-75627462-C-T RECQL5-related disorder • not specified Uncertain significance (Mar 01, 2024)2344935
17-75627467-G-A RECQL5-related disorder Likely benign (Jan 23, 2024)3036767
17-75627473-G-A RECQL5-related disorder Likely benign (Aug 04, 2022)3051239
17-75627526-C-T RECQL5-related disorder Likely benign (Sep 08, 2022)3032266
17-75627617-G-A Benign (Dec 31, 2019)721351
17-75627670-C-T RECQL5-related disorder Benign (Nov 16, 2019)719399
17-75627671-G-A not specified Uncertain significance (Feb 17, 2022)2365236
17-75627673-G-A not specified Uncertain significance (Nov 30, 2022)2408773
17-75627681-T-A not specified Uncertain significance (Dec 15, 2023)3152855
17-75627694-T-C Likely benign (Dec 31, 2019)721458
17-75628268-C-T not specified Uncertain significance (Jan 26, 2023)2472203
17-75628270-A-G not specified Uncertain significance (Feb 21, 2024)3152854
17-75628273-T-G RECQL5-related disorder Likely benign (Feb 28, 2022)715821
17-75628279-G-A not specified Uncertain significance (Oct 05, 2023)3152853
17-75628295-C-T RECQL5-related disorder Uncertain significance (Nov 28, 2022)2634631
17-75628304-C-T not specified Uncertain significance (Nov 15, 2021)2409062
17-75628306-G-C not specified Uncertain significance (Dec 19, 2022)2358490
17-75628307-A-G not specified Likely benign (Mar 27, 2023)2530143
17-75628327-G-C not specified Uncertain significance (Dec 19, 2022)2337075
17-75628354-C-G not specified Uncertain significance (Sep 26, 2022)2313407
17-75628385-C-T RECQL5-related disorder Likely benign (Dec 01, 2022)2648275
17-75628386-G-A RECQL5-related disorder Benign (Dec 16, 2019)3039708
17-75628388-C-T RECQL5-related disorder Uncertain significance (Jan 12, 2024)3040343
17-75628392-G-C RECQL5-related disorder Likely benign (Jan 19, 2023)3055107

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
RECQL5protein_codingprotein_codingENST00000317905 1940345
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
3.17e-180.3811256600881257480.000350
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-0.004555775771.000.00003576399
Missense in Polyphen154169.660.90771873
Synonymous0.2152272310.9820.00001431985
Loss of Function1.683446.30.7340.00000235549

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0007450.000735
Ashkenazi Jewish0.000.00
East Asian0.0002210.000217
Finnish0.0004770.000462
European (Non-Finnish)0.0003720.000316
Middle Eastern0.0002210.000217
South Asian0.0006220.000621
Other0.0003280.000326

dbNSFP

Source: dbNSFP

Function
FUNCTION: Isoform beta is a DNA helicase that plays an important role in DNA replication, transcription and repair. Inhibits elongation of stalled transcripts at DNA damage sites by binding to the RNA polymerase II subunit POLR2A and blocking the TCEA1 binding site. Required for mitotic chromosome separation after cross-over events and cell cycle progress. Required for efficient DNA repair, including repair of inter-strand cross-links. Stimulates DNA decatenation mediated by TOP2A. Prevents sister chromatid exchange and homologous recombination. {ECO:0000269|PubMed:20231364, ECO:0000269|PubMed:20348101, ECO:0000269|PubMed:20643585, ECO:0000269|PubMed:22013166, ECO:0000269|PubMed:22973052, ECO:0000269|PubMed:23715498, ECO:0000269|PubMed:23748380}.;

Recessive Scores

pRec
0.226

Intolerance Scores

loftool
0.891
rvis_EVS
0.15
rvis_percentile_EVS
63.68

Haploinsufficiency Scores

pHI
0.144
hipred
Y
hipred_score
0.663
ghis
0.509

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.575

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumHigh
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Recql5
Phenotype
cellular phenotype;

Gene ontology

Biological process
mitotic sister chromatid segregation;mitotic cell cycle;double-strand break repair via homologous recombination;DNA metabolic process;DNA replication;DNA repair;DNA recombination;response to X-ray;DNA duplex unwinding;negative regulation of transcription elongation from RNA polymerase II promoter;negative regulation of mitotic cell cycle;cell division;chromosome separation;cellular response to camptothecin;replication-born double-strand break repair via sister chromatid exchange;negative regulation of double-strand break repair via homologous recombination
Cellular component
nucleus;nucleoplasm;chromosome;cytoplasm;cytosol;RNA polymerase II, holoenzyme
Molecular function
RNA polymerase II complex binding;DNA binding;DNA helicase activity;ATP binding;four-way junction helicase activity;identical protein binding;ATP-dependent 3'-5' DNA helicase activity